Description
Description
Live attenuated vaccines developed by many research groups are based on Genotype-II of African swine fever virus, predominantly present in Europe
and Asia. Presence of 24 different genotypes in Africa, some genetically very distant. There is no testing on the impact (potential risk or benefit) the developed ASF vaccines will have in the African context.
Comments
Add new comment